Redmile Group, LLC

SEC CIK: 0001425738
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

OVID holding history

Ovid Therapeutics Inc. in every 13F filed by Redmile Group, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OVID overview All 13F holders of OVID Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q1 2021

Holdings of OVID by Redmile Group, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−40,674−100.0%	Sold out	Holders
Q3 2021	40,674	$137.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2021	40,674	$159.0K	<0.1%	−81,276−66.6%	Reduced	Holders
Q1 2021	121,950	$490.0K	<0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.